Post-COVID in patients with immune-mediated inflammatory diseases: prospective multidimensional evaluatio

Recruiting

• Conditions: K50.9; Crohn disease, unspecified; K51.9; Ulcerative colitis, unspecified

• Registration Number: DRKS00028880
• Lead Sponsor: niversitätsklinikum Leipzig

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2022-06-14
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 200

Inclusion Criteria

immune-mediated disease as established by experienced physiscian
- willing to take part in the survey

Exclusion Criteria

- lack of cognitive ability to take part
- acute SARS-CoV2-infection (proven/suspected)

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
ife-quality (SIBDQ; PHQ-4; EQ5D-DL; HAQ) differences in patients with survived COVID-19 against patients without diagnosed COVID-19 in a population with immune-mediated diseases.<br>The questionnaire will be used once the patient is found eligible.

Secondary Outcome Measures

Name	Time	Method
Post-COVID sysmptoms in relation to<br>- age/gender<br>- heigth/weight/BMI/nicotine consumption<br>- leukocytes/CrP<br>- mediacation<br>- comorbidities<br>- severitiy of COVID-19<br>- time and length of COVID-19<br>- autoimmune disease activity